Establishment and characterization of an in vivo model for Epstein-Barr virus positive gastric carcinoma

Journal of Medical Virology

Volumn 79, Issue 9, 2007, Pages 1343-1348

  Sang, Taek Oh ^a   Cha, Jung Ho ^a   Shin, Dong Jik ^a,b   Sungjoo, Kim Yoon ^a   Suk, Kyeong Lee ^a  

^a The Catholic University of Korea   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Epstein Barr virus; Gastric carcinoma; In vivo model; Tumorigenesis

Indexed keywords

VIRUS DNA;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE MODEL; EBER GENE; EBNA1 GENE; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION REGULATION; IN VIVO STUDY; LMP2A GENE; MOUSE; NONHUMAN; NUDE MOUSE; STOMACH CANCER CELL SNU 719; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; VIRUS CHARACTERIZATION;

ANIMALS; CELL LINE, TUMOR; EPSTEIN-BARR VIRUS INFECTIONS; GENOTYPE; HERPESVIRUS 4, HUMAN; MICE; MICE, NUDE; STOMACH NEOPLASMS; VIRUS LATENCY;

HUMAN HERPESVIRUS 4; MUS MUSCULUS;

EID: 34547129323     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20876     Document Type: Article

References (32)

1. Albini A, Melchiori A, Garofalo A, Noonan DM, Basolo F, Taraboletti G, Chader GJ, Gavazzi R. 1992. Matrigel promotes retinoblastoma cell growth in vitro and in vivo. Int J Cancer 52:234-240.
2. Burke AP, Yen TS, Shekitka KM, Sobin LH. 1990. Lymphoepithelial carcinoma of the stomach with Epstein-Barr virus demonstrated by polymerase chain reaction. Mod Path 3:370-380.
3. Chong JM, Fukayama M, Hayashi Y, Takizawa T, Koike M, Konishi M, Kikuchi-anoshita R, Miyaki M. 1994. Microsatellite instability in the progression of gastric carcinoma. Cancer Res 54:4595-4597.
4. Cowell JK, Ramani P, Song Y, Evans M, Morgan G. 1997. The use of SCID mice for the growth of retinoblastoma cell lines and for the establishment of xenografts from primary tumours. Eur J Cancer 33:1070-1107.
5. Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL. 1990. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci USA 87:6698-6702.
6. Fukayama M, Hayashi Y, Iwasaki Y, Chong JM, Ooba T, Takizawa T, Koike M, Mizutani S, Miyaki M, Hirai K. 1994. Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 71:73-81.
7. Fukayama M, Chong JM, Uozaki H. 2001. Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. Curr Top Microbiol Immunol 258:91-102.
8. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. 1996. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum Pathol 27:20-27.
9. Han MS, Kang PW, Choi DH, Lee YH, Choi SK, Yoon SR, Shin DJ, Kim JM, Jin HJ, Kwak KD, Kim W. 2001. Korean population genetic data for eleven STR loci. Forensic Sci Int 123:230-231.
10. Imai S, Koizumi S, Sugiura M, Tokunaga M, Uemura Y, Yamamoto N, Tanaka S, Sato E, Osato T. 1994. Gastric carcinoma: Monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc Natl Acad Sci USA 13:9131-9135.
11. Imai S, Nishikawa J, Kuroda M, Takada K. 2001. Epstein-Barr virus infection of human epithelial cells. Curr Top Microbiol Immunol 258:161-184.
12. Iwasaki Y, Chong JM, Hayashi Y, Ikeno R, Arai K, Kitamura M, Koike M, Hirai K, Fukayama M. 1998. Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice. J Virol 72:8321-8326.
13. Kawa K. 2000. Epstein-Barr virus-associated diseases in humans. Int J Hematol 71:108-117.
14. Lin JC, Lin SC, De BK, Chan WP, Evatt BL, Chan WC. 1993. Precision of genotyping of Epstein-Barr virus by polymerase chain reaction using three gene loci (EBNA-2, EBNA-3C, and EBER): Predominance of type A virus associated with Hodgkin's disease. Blood 81:3372-3381.
15. Lynch HT, Grady W, Suriano G, Huntsman D. 2005. Gastric cancer: New genetic developments. J Surg Oncol 90:114-133.
16. MacPherson I, Montagner L. 1964. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23:291-294.
17. Mettlin C. 1998. Levels of epidemiologic proof in studies of diet and cancer with special reference to dietary fat and vitamin A. Prog Clin Biol Res 259:149-159.
18. Moon A, Kim MS, Kim TG, Kim SH, Kim HE, Chen YQ, Kim HR. 2000. H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the H-ras-induced invasive phenotype. Int J Cancer 85:176-181.
19. Murakami M, Hoshikawa Y, Satoh Y, Ito H, Tajima M, Okinaga K, Miyazawa Y, Kurata T, Sairenji T. 2000. Tumorigenesis of Epstein-Barr virus-positive epithelial cell lines derived from gastric tissues in the SCID mouse. Virology 277:20-26.
20. Oh ST, Seo JS, Moon UY, Kang KH, Shin DJ, Yoon SK, Kim WH, Park JG, Lee SK. 2004. A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer. Virology 320:330-336.
21. Okano M, Gross TG. 2000. A review of Epstein-Barr virus infection in patients with immunodeficiency disorders. Am J Med Sci 319:392-396.
22. Ott G, Kirchner T, Muller-Hermelink HK. 1994. Monoclonal Epstein-Barr virus genomes but lack of EBV-related protein expression in different types of gastric carcinoma. Histopathology 25:323-329.
23. Park JG, Yang HK, Kim WH, Chung JK, Kang MS, Lee JH, Oh JH, Park HS, Yeo KS, Kang SH, Song SY, Kang YK, Bang YJ, Kim YH, Kim JP. 1997. Establishment and characterization of human gastric carcinoma cell lines. Int J Cancer 70:443-449.
24. Raab-Traub N, Flynn K. 1986. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 26:883-889.
25. Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A, Kieff E. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 64:4084-4092.
26. Shibata D, Weiss LM. 1992. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140:769-774.
27. Soule HD, Maloney TM, Wolman SR, Peterson WD, Jr., Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. 1990. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50:6075-6086.
28. Sugiura M, Imai S, Tokunaga M, Koizumi S, Uchizawa M, Okamoto K, Osato T. 1996. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: Unique viral latency in the tumour cells. Br J Cancer 74:625-631.
29. Tajima M, Komuro M, Okinaga K. 1998. Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn J Cancer Res 89:262-268.
30. Takada K. 2000. Epstein-Barr virus and gastric carcinoma. Mol Pathol 53:255-261.
31. van Beek J, zur Hausen A, Kranenbarg EK, Warring RJ, Bloemena E, Craanen ME, van de Velde CJ, Middeldrop JM, Meijer CJ, van den Brule AJ. 2002. A rapid and reliable enzyme immunoassay PCR-based screening method to identify EBV-carrying gastric carcinomas. Mod Path 15:870-877.
32. zur Hausen A, Brink AA, Craanen ME, Middeldrop JM, Meijer CJ, van den Brule AJ. 2002. Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas: Expression of the transforming BARF1 gene. Cancer Res 15:2745-2748.